FDA Approves Medtronic’s Resolute Onyx DES With Short-Term Dual-Antiplatelet Therapy

MDT Onyx Clear
Medtronic's Resolute Onyx zotarolimus-eluting coronary stent • Source: Medtronic PLC

More from Approvals

More from Policy & Regulation